Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 48 Leukemia 41 Breast Neoplasms 28 Lymphoma 21 Leukemia, Myeloid, Acute 16 Burkitt Lymphoma 13 Myelodysplastic Syndromes 11 Graft vs Host Disease 10 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Urinary Bladder Neoplasms 5 Leukemia, Promyelocytic, Acute 5 Hodgkin Disease 5 Anemia, Refractory, with Excess of Blasts 5 Osteosarcoma 4 Myeloproliferative Disorders 4 Lymphoma, Follicular 4 Leukemia, Myelomonocytic, Chronic 4 Head and Neck Neoplasms 4 Arthritis, Rheumatoid 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

tofacitinib 7 Etanercept 4 Adalimumab 2 secukinumab 1 apremilast 1 Methotrexate 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Psoriasis × Methotrexate × Clear all

NCT02196701 2018-03-19

CLEAR

AbbVie

Phase 3 Completed

46 enrolled 27 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡